Year: 2025

Vancouver, Canada, Nov. 13, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received final approval from the Hadassah Medical Center, Jerusalem, Israel, for its ongoing Phase 1/2a clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This approval will enable Hadassah Medical Center, a leading clinical site in Israel, to join the Company’s clinical trial, of which the first cohort treatment was successfully completed.  The trial includes other first-in-class institutions, such as Yale School of Medicine’s...

Tampa Bay, Florida, Nov. 13, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced a second purchase order (“PO”) from a Fortune 50 telecommunications company. Under this agreement, Draganfly will deliver multiple units of its Commander 3XL platform integrated with Unmanned Systems & Solutions Inc. (“USaS”) LEAP® tether system. This order marks a major expansion and standardization of the customer’s National Defense Authorization Act (NDAA)-compliant drone fleet for emergency management and post-disaster telecommunication support. The order leverages Draganfly’s NDAA multi-mission Commander 3XL drone combined with USaS’s proven tethered-power and communications infrastructure to...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an Off-the-Shelf CD19-targeted CAR T-cell Product Candidate that Utilizes Less-intensive or No Conditioning, Enabling Broad Patient Accessibility First Systemic Sclerosis Patient treated in Phase 1 Study of FT819 Following Fludarabine-free Conditioning; Dose Expansion Designed to Evaluate Patient Outcome with Less-intensive or No Conditioning First Patient Treated with FT836, a MICA/B-targeted Off-the-Shelf CAR T cell with Sword and ShieldTM Technology for Conditioning-free Treatment of a Broad Array of Solid Tumors Projected Operating Runway Through Year-End 2027 to Enable Achievement of Key Clinical and Collaboration Milestones with $226 Million in Cash, Cash Equivalents, and Investments SAN DIEGO,...

BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its senior leadership team will present at the prestigious Jefferies London Healthcare Conference. Chief Executive Officer Ivor Elrifi and Chief Operating Officer/Chief Financial Officer Keeren Shah will deliver a corporate overview highlighting the Company’s innovative pipeline and recent clinical milestones. The session will include an update on the lead candidate foralumab, the only fully human anti-CD3 monoclonal antibody in clinical development administered intranasally for neurodegenerative diseases such as non-active...

New CTO, Mandeep Singh, to Lead ECGI’s Development of AI-Powered Mortgage Tokenization Systems and Automated On-Chain Treasury Intelligence IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — ECGI Holdings, Inc. (OTC:ECGI) announced today that Mandeep Singh has been appointed Chief Technology Officer to spearhead the design and deployment of the company’s AI-driven mortgage tokenization infrastructure. Singh will architect the platform that powers ECGI’s next phase of technology expansion, including real-time asset intelligence and automated, on-chain treasury systems that support the multi-trillion-dollar mortgage lending markets. Singh brings more than a decade of experience in machine learning, quantitative financial modeling and decentralized systems. Most recently, he led GenAI platform integration and ML infrastructure...

LONGBOAT KEY, FL, Nov. 13, 2025 (GLOBE NEWSWIRE) — Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced a partnership with the Cleveland Browns to provide the infrastructure services of the Rumble Cloud. As part of the agreement, Rumble will provide video cloud storage for the Browns. “When you’re running a football team and trying to win games, the last thing you want anyone thinking about is data storage problems, which is why it’s so fantastic for Rumble Cloud to partner with the Cleveland Browns,” said Rumble Chief Executive Officer Chris Pavlovski. “We are extremely proud of our new relationship with the Browns, such a high-profile and respected organization, because this further solidifies Rumble Cloud as a high-performance, cost-effective, first-option cloud provider.” “We’re always...

Acquisition of Champion’s Lewisberry, PA Location Drives Major Expansion for Northeast Retailer Provo, UT, Nov. 13, 2025 (GLOBE NEWSWIRE) — Champion Safe Company (championsafe.com), a premier manufacturer of high-security safes and a proud subsidiary of American Rebel Holdings, Inc. (NASDAQ: AREB), America’s Patriotic Brand, proudly recognizes SafeSource USA for its outstanding 92% year-to-date growth in 2025, based on orders placed with Champion Safe Company compared to 2024. The surge follows SafeSource’s 2024 acquisition and enhancement of Champion’s Lewisberry, PA facility — now operating as SafeSource PA — and underscores the retailer’s rapid expansion across the Northeast.SafeSource USA, a fourth-generation safe and vault door retailer, has been a trusted Champion retail partner since 2013. Known for their unmatched expertise...

SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer”), a world-leading technology company for Bitcoin mining and AI cloud, today announced the pricing of its registered direct offering of 10,661,140 of its Class A ordinary shares, par value US$0.0000001 per share (the “Class A ordinary shares”), to certain holders of its 5.25% convertible senior notes due 2029 (the “November 2029 notes”) at a price of US$13.94 per Class A ordinary share in a direct placement registered under the Securities Act of 1933, as amended (the “Securities Act”) (such placement, the “registered direct offering”). The registered direct offering is expected to close on November 19, 2025, subject to customary closing conditions. Bitdeer estimates that the net proceeds from the registered direct offering will be approximately...

SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer”), a world-leading technology company for Bitcoin mining and AI cloud, today announced the pricing of US$400.0 million principal amount of 4.00% Convertible Senior Notes due 2031 (the “notes”) in a private placement (the “notes offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Bitdeer also granted the initial purchasers of the notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional US$60.0 million principal amount of notes. The sale of the notes is expected to close on November 17, 2025, subject to customary closing...